$SNY 3 SEC Filings

Filed On	Filing
12 Aug 2026	Form 3: Sanofi, 10% owner · Latigo Biotherapeutics, Inc.
04 Aug 2026	Form 3: Sanofi, 10% owner · Attovia Therapeutics Inc
13 Aug 2024	Form 3: Sanofi, 10% owner · MeiraGTx Holdings PLC Holds 11,500,000 shares of Ordinary Shares ($0.00003881 par value per share)
12 Aug 2021	Form 3: Sanofi, See Remarks below · Translate Bio, Inc. Holds 3,684,434 shares of Common Stock
28 Jul 2021	Form 3: Sanofi, 10% owner · Icosavax, Inc.
23 Jul 2020	Form 3: Sanofi, 10% owner · Inozyme Pharma, Inc.
17 Jul 2019	Form 3: Sanofi, 10% owner · Fulcrum Therapeutics, Inc.
12 Nov 2015	Form 3: Sanofi, 10% owner · Voyager Therapeutics, Inc.
28 Oct 2015	Form 3: Sanofi, 10% owner · MyoKardia, Inc.
09 May 2014	Form 3: Sanofi, 10% owner · SCYNEXIS Inc Holds 48,751 shares of Shares
03 Mar 2014	Form 3: Sanofi, 10% owner · Alnylam Pharmaceuticals, Inc. Holds 8,766,338 shares of Common Stock
07 Nov 2013	Form 3: Sanofi, 10% owner · Crescent Biopharma, Inc. Holds 1,193,625 shares of Preferred Stock
09 Oct 2012	Form 3: Sanofi, 10% owner · Regulus Therapeutics Inc. Holds 3,749,999 shares of Common Stock
10 Aug 2012	Form 3: Sanofi, 10% owner · HUMANIGEN, INC
06 Apr 2011	Form 3: Sanofi-aventis, 10% owner and 1 other · GENZYME CORP Holds 184,038,545 shares of Common Stock, $0.01 par value
11 Feb 2010	Form 3: Sanofi-aventis, 10% owner and 3 others · CHATTEM INC Holds 15,757,789 shares of Common Stock, without par value
21 Dec 2007	Form 3: Sanofi-aventis, 10% owner and 1 other · Regeneron Pharmaceuticals, Inc. Holds 14,799,552 shares of Common Stock, $.001 par value
26 Aug 2005	Form 3: Sanofi-aventis, 10% owner · IDM PHARMA, INC. Holds 1,986,740 shares of Common Stock, $0.01 par value

Comments